BioXcel Therapeutics Inc Working Capital to Net Assets Ratio
BioXcel Therapeutics Inc working capital to net assets ratio. BioXcel Therapeutics Inc (BTAI) has a Working Capital to Net Assets ratio of 93.9% as of June 2026. Working capital of $-108.45 Million (current assets of $28.70 Million minus current liabilities of $137.15 Million) is measured against net assets of $-115.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check BioXcel Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of BioXcel Therapeutics Inc (2015–2025)
Working capital to net assets ratio of BioXcel Therapeutics Inc from 2015 to 2025. This chart shows how BioXcel Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 93.9%, reflecting working capital of $-108.45 Million against net assets of $-115.46 Million USD. See BioXcel Therapeutics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
BioXcel Therapeutics Inc Working Capital to Net Assets Ratio by Year (2015–2025)
BioXcel Therapeutics Inc working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for BioXcel Therapeutics Inc from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BTAI asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 9.7% | $-9.24 Million | $-95.46 Million | $44.69 Million | $53.93 Million | ▲ +26.0 pp |
| 2024 | -16.3% | $15.16 Million | $-93.10 Million | $37.39 Million | $22.23 Million | ▲ +63.1 pp |
| 2023 | -79.4% | $44.88 Million | $-56.51 Million | $72.14 Million | $27.27 Million | ▼ -300.8 pp |
| 2022 | 221.4% | $169.97 Million | $76.78 Million | $202.87 Million | $32.90 Million | ▲ +122.1 pp |
| 2021 | 99.3% | $220.15 Million | $221.67 Million | $236.81 Million | $16.67 Million | ▲ +0.0 pp |
| 2020 | 99.3% | $205.22 Million | $206.70 Million | $217.06 Million | $11.84 Million | ▲ +4.0 pp |
| 2019 | 95.3% | $25.64 Million | $26.89 Million | $34.11 Million | $8.47 Million | ▼ -3.7 pp |
| 2018 | 99.0% | $38.51 Million | $38.89 Million | $43.17 Million | $4.66 Million | ▼ -48.3 pp |
| 2017 | 147.4% | $-1.45 Million | $-982.00K | $890.00K | $2.34 Million | ▲ +45.8 pp |
| 2016 | 101.5% | $-329.00K | $-324.00K | $2.00K | $331.00K | ▲ +1.0 pp |
| 2015 | 100.6% | $-174.00K | $-173.00K | $1.00K | $175.00K | — |